Ocugen
OCGN
128 hedge funds and large institutions have $147M invested in Ocugen in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 35 reducing their positions, and 15 closing their positions.
67% more call options, than puts
Call options by funds: $3.28M | Put options by funds: $1.97M
27% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 15
23% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 35
3% more funds holding
Funds holding: 124 → 128 (+4)
1.43% less ownership
Funds ownership: 39.45% → 38.02% (-1.4%)
24% less capital invested
Capital invested by funds: $193M → $147M (-$46.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$2.96M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$1.81M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$1.45M |
| 4 |
Rafferty Asset Management
New York
|
+$1.36M |
| 5 |
Goldman Sachs
New York
|
+$1.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$11.5M |
| 2 |
Morgan Stanley
New York
|
-$5.21M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.46M |
| 4 |
Renaissance Technologies
New York
|
-$1.41M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$775K |
OCGN Hedge Fund Activity: Q3 2022 in Review
128 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Ocugen (OCGN) for Q3 2022, worth a combined $147M — down 24% from $193M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new OCGN positions and 15 closed out — a net gain of 4 holders — while 43 added to existing stakes and 35 trimmed.
The largest buyer was Barclays, adding an estimated $2.96M. The largest seller was State Street, cutting an estimated $11.5M.
- 128 institutional investors held Ocugen (OCGN) as of Q3 2022, up from 124 in Q2 2022.
- Funds reported $147M of Ocugen stock for Q3 2022, down 24% quarter-over-quarter.
- 19 funds opened new Ocugen positions in Q3 2022 and 15 closed out, a net change of +4 holders.
- The largest Ocugen buyer in Q3 2022 was Barclays, an estimated $2.96M added.
- The largest Ocugen seller in Q3 2022 was State Street, an estimated $11.5M sold.
Based on aggregated 13F filings for Q3 2022.